Orthofix (NSDQ:OFIX) today announced that it has launched its FiberFuse Strip bone graft in the U.S.
Lewisville, Texas–based Orthofix designed the FiberFuse Strip to be a preformed bone-graft strip for posterior cervical, posterior lumbar and degenerative spinal procedures.
FiberFuse Strip is 100% bone and has a unique mixture of mineralized cancellous and demineralized cortical bone with no carrier added. It creates a natural scaffold to allow for revascularization, cellular ingrowth and new bone formation.
“We are pleased to introduce this next-generation formulation in the FiberFuse allograft line,” Orthofix global spine president Kevin Kenny said in a news release. “The FiberFuse Strip delivers a high-quality advanced bone-graft option in a convenient, easy-to-use strip preparation. This technology advancement was developed as part of our strategy to provide procedurally-focused solutions for spine surgeons and their patients.”
MTF Biologics is the processor of Orthofix’s FiberFuse Strip. Its validated aseptic processing method retains the natural growth factors within the cortical fibers, according to the company. The fibers interconnect to form a pliable, cohesive graft and the cancellous matrix provides a porous scaffold to allow for ingrowth of vasculature, osteoblasts and mesenchymal stem cells.
